戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tely and died by 4 months of age with severe hypoxemia.
2 he venular endothelium to the same extent as hypoxemia.
3 nal endothelial cell injury) associated with hypoxemia.
4 e control group received HFOV for refractory hypoxemia.
5 ble coughing, urticaria, edema, wheezing and hypoxemia.
6 copy following hypoventilation, may decrease hypoxemia.
7  in patients with severe ARDS and refractory hypoxemia.
8 e development of life-threatening refractory hypoxemia.
9 ked by impaired gas exchange and significant hypoxemia.
10 esterol levels, compared to subjects without hypoxemia.
11 me oxygen values, have only mild to moderate hypoxemia.
12  dyspnea and oxygen for short-term relief of hypoxemia.
13 ems accurate, especially for moderate-severe hypoxemia.
14 and body mass index influenced ictal-related hypoxemia.
15  management of silent infarcts and nocturnal hypoxemia.
16 ation in critically ill patients with severe hypoxemia.
17 o are oxygen non-responsive with intractable hypoxemia.
18 ntially aggravating systemic hypercarbia and hypoxemia.
19  pulmonary disease (COPD) and severe resting hypoxemia.
20 BCs is impaired in diseases characterized by hypoxemia.
21 e lung injury, patchy alveolar flooding, and hypoxemia.
22 ion and pulmonary arterial hypertension with hypoxemia.
23 t-to-left shunt pathophysiology and systemic hypoxemia.
24 and concerns over hypercapnia, acidosis, and hypoxemia.
25 ake at anaerobic threshold, and 54 developed hypoxemia.
26 ce of acute lung injury and resultant severe hypoxemia.
27 of infant human and rabbit hearts to chronic hypoxemia.
28 aryngoscopy (apneic oxygenation) may prevent hypoxemia.
29 d for oxygen and is especially vulnerable to hypoxemia.
30 cardia did not alter the prognostic value of hypoxemia.
31 mes were similarly increased after prolonged hypoxemia.
32 to safety process measures, and frequency of hypoxemia.
33 dent sympathetic activation and/or degree of hypoxemia.
34 ochemical indicators of vitamin A status and hypoxemia.
35 atients is frequently associated with severe hypoxemia.
36  fetus as growth restriction and progressive hypoxemia.
37 la may offer an alternative in patients with hypoxemia.
38  including the management of HPS with severe hypoxemia.
39 are similar to those of SCD mice but without hypoxemia.
40 ts was associated with a lower prevalence of hypoxemia (10.1% vs. 17.4%, p = .022) and a lower preval
41  in more than one patient included transient hypoxemia (19%), radiation pneumonitis (11%), and fatigu
42 sk group experienced more episodes of severe hypoxemia (2% vs 14%, p = 0.03).
43  in the presence of respiratory distress and hypoxemia (2C), use of physical examination therapeutic
44  subjects with severe COPD and only moderate hypoxemia; (3) efficacy of nocturnal O(2) supplementatio
45 e likely than those with normal CXRs to have hypoxemia (45% vs 26%), crackles (69% vs 62%), tachypnea
46  transfusion, higher fluid balance, obesity, hypoxemia, acidosis, tobacco use, emergent hematoma evac
47   Randomized clinical trial of patients with hypoxemia after cardiac surgery at a single ICU in Brazi
48                          Among patients with hypoxemia after cardiac surgery, the use of an intensive
49 bation and improve outcomes of patients with hypoxemia after cardiothoracic surgery.
50 ere 67% and 52% (P = .02), and for recurrent hypoxemia after oxygen supplementation were 38% and 18%
51                                          The hypoxemia after sildenafil administration in group B imp
52 ium further than either hemorrhagic shock or hypoxemia alone did.
53                                              Hypoxemia also triggered leukocytes adhesion to the venu
54                                    Nocturnal hypoxemia, an important pathophysiological feature of OS
55 t the immediate implementation of permissive hypoxemia and a comprehensive evaluation of its value in
56 ficant correlations noted between CYP2E1 and hypoxemia and beta-OH butyrate suggest that these factor
57       To examine whether patients with acute hypoxemia and bilateral opacities treated with high-flow
58 n is influenced by the severity of nocturnal hypoxemia and comorbid obesity has not been determined.
59 of dyspnea and fatigue, partially related to hypoxemia and compromised oxygen delivery.
60 dema) in the alveolar airspaces and leads to hypoxemia and death if not corrected.
61                                              Hypoxemia and enhanced ventilatory demands result, altho
62 vel to altitude, but this may expose them to hypoxemia and exacerbation of sleep apnea.
63                           The association of hypoxemia and hemorrhagic shock did not amplify leukocyt
64                           The association of hypoxemia and hemorrhagic shock did not further amplify
65                                        Ictal hypoxemia and hypercapnia may contribute to SUDEP.
66                    These effects, as well as hypoxemia and hypotension, were prevented by 3-aminobenz
67 tein-rich pulmonary edema that causes severe hypoxemia and impaired carbon dioxide excretion.
68 atous optic neuropathy by creating transient hypoxemia and increasing vascular resistance.
69 ng transplant and is characterized by severe hypoxemia and infiltrates in the allograft.
70 ciation was partially explained by overnight hypoxemia and less so by sleep duration.
71 ion of the great arteries is associated with hypoxemia and longer time to surgery.
72 lps detect extracardiac pathology leading to hypoxemia and may be used to guide fluid resuscitation a
73 ificantly associated with the level of fetal hypoxemia and metabolic stress.
74 ease are at risk for respiratory failure and hypoxemia and need to be screened for hepatopulmonary sy
75 is associated with a decreased prevalence of hypoxemia and reduced rate of procedure-related complica
76  physiologic factors, such as propensity for hypoxemia and respiratory arousability.
77 main patent and subject patients to arterial hypoxemia and risk for paradoxical emboli.
78 l life support can lead to rapid reversal of hypoxemia and shock; however, it can also result in vary
79 long-term survival relative to the degree of hypoxemia and the era in which LT was conducted.
80 he severity of lung injury and the degree of hypoxemia and/or the effects of ventilator settings on g
81                                   Refractory hypoxemia and/or uncompensated hypercapnia despite optim
82 a, and hypomagnesemia; 14 patients (52%) had hypoxemia, and 9 (33%) had oliguria, of whom 5 had anuri
83 ATP content of bronchoalveolar lavage fluid, hypoxemia, and altered nasal potential difference.
84 cular outflow tract obstruction, unexplained hypoxemia, and aortic dissection, among others, can all
85  reducing the frequency of hypoxemia, severe hypoxemia, and apnea.
86 rapy were associated significantly with LRD, hypoxemia, and death.
87 o mobilization were hemodynamic instability, hypoxemia, and dependency on venovenous extracorporeal m
88 ermeability pulmonary edema, severe arterial hypoxemia, and impaired carbon dioxide excretion.
89 rs appear to be exaggerated polycythemia and hypoxemia, and lower and sluggish CBF compared to CMS pa
90 ed sympathetic activity, hemodynamic stress, hypoxemia, and oxidative stress.
91 rioration, sepsis, hyperleukocytosis, severe hypoxemia, and prolonged mechanical ventilation.
92 1 had lower respiratory tract disease (LRD), hypoxemia, and prolonged viral shedding compared with se
93 infected mice from weight loss, hypothermia, hypoxemia, and respiratory compromise.
94  >/=90% [moderate hypoxemia] or <90% [severe hypoxemia]) and 13 obese control subjects.
95 ry end points were the occurrences of severe hypoxemia, apnea, and oxygen supplementation.
96                                              Hypoxemia appears to be an important factor that underli
97  Obstructive sleep apnea (OSA) and nocturnal hypoxemia are associated with chronic kidney disease and
98 ce rate of ICU-acquired infection and severe hypoxemia are expected outcomes from RBC transfusion tha
99  determine the effect of postoperative IS on hypoxemia, arterial oxygen saturation (Sao2) level, and
100 ntrol of arterial oxygenation and permissive hypoxemia as candidate management strategies in hypoxemi
101  in subsets of patients with mild and severe hypoxemia as defined by PaO(2)/Fio(2).
102  harm will aid the development of permissive hypoxemia as viable clinical strategy.
103  acute myocardial infarction who do not have hypoxemia at baseline is uncertain.
104                   We postulate that arterial hypoxemia at high altitude poses a risk of faster diseas
105                            More than 40% had hypoxemia at rest (13%) or on exercise (29%), with pulmo
106 rtality, ICU-acquired infections, and severe hypoxemia) at day 30, we used marginal structural models
107 yndrome in acute liver failure are scant and hypoxemia being a commonly encountered systemic complica
108 nt differences in frequency of postoperative hypoxemia between the control and test groups were found
109 horacentesis may be complicated by transient hypoxemia, bleeding, patient discomfort, reexpansion pul
110                Failure to recognize spurious hypoxemia can lead to unnecessary diagnostic tests and t
111 rtality, which was accompanied by attenuated hypoxemia, cardiopulmonary dysfunction, and pulmonary ed
112 e the clearance of Abeta from the brain, and hypoxemia characteristic of sleep-disordered breathing i
113 gue muscles are coactivated in conditions of hypoxemia comparable to that experienced by adults with
114 ardia, tachypnea, hypotension, and prolonged hypoxemia compared with controls.
115 oxygenation and reduced prevalence of severe hypoxemia compared with nonrebreathing bag reservoir fac
116 se to AngII was less in patients with severe hypoxemia compared with those with moderate hypoxemia (P
117 agic telangiectasia: iron deficiency impairs hypoxemia compensations by restricting erythropoiesis an
118  During hemorrhagic shock, the occurrence of hypoxemia considerably alters villous intestinal perfusi
119                                The impact of hypoxemia correction on liver disease severity warrants
120                             Higher levels of hypoxemia correlated with increased volume and thickness
121 case identification that included the milder hypoxemia criterion for ALI would yield incidence number
122                                              Hypoxemia decreased RBCs velocity in intestinal villi bu
123         The primary outcome was frequency of hypoxemia, defined as an Sao2 level of less than 92% wit
124 ectin-1:mIgG1 and Dectin-1:mIgG2a Fc reduced hypoxemia despite minimal effects on fungal burden in th
125 atic sickle cell disease exacerbated by mild hypoxemia, despite a newborn-screening diagnosis of sick
126                                              Hypoxemia developed in 62 patients (1.9%) in the oxygen
127                                              Hypoxemia developed in 69% of patients in the blinded ar
128  that trigger white matter injury, transient hypoxemia disrupted SPN arborization and functional matu
129 rs in sepsis patients with severe refractory hypoxemia due to ARDS (2C); prone positioning in sepsis-
130 ve sleep apnea is primarily characterized by hypoxemia due to frequent apneic episodes and fragmentat
131  of advanced liver disease, characterized by hypoxemia due to intrapulmonary vascular dilatations.
132                                              Hypoxemia, due to a number of different reasons, is comm
133 cted at limiting the duration or severity of hypoxemia during brain development may mitigate disturba
134 of oxygen delivery and, thus, is at risk for hypoxemia during emergency airway management.
135 warning system for hypoxemia, would decrease hypoxemia during endoscopy.
136  to providing a reasonable safeguard against hypoxemia during laryngoscopy and endotracheal intubatio
137                                Treatment for hypoxemia during OLV also needs to be modified.
138  = 0.03) and subjects with any two events of hypoxemia during sedation, maintenance or recovery were
139                                       Marked hypoxemia during sleep may occur in hepatopulmonary synd
140 ge in body mass index, severity of nocturnal hypoxemia, E/E', and sex were independently associated w
141  hyperalgesia in volunteers, while nocturnal hypoxemia enhanced morphine analgesic potency in childre
142     No systemic hypertension and no arterial hypoxemia existed to explain the PAH.
143       Mean percentages of recorded time with hypoxemia for the least and most affected 10% of infants
144                                           As hypoxemia frequently occurs simultaneously with hemorrha
145               Mice were randomly assigned to hypoxemia group in which we decreased inspired oxygen fr
146             We now studied if mild prolonged hypoxemia had an adverse effect on the fetal cardiovascu
147       Transplant recipients with more severe hypoxemia had increased risk of death after liver transp
148                                        Ictal hypoxemia has been reported in small series of cases and
149 EAS) for severe left atrial hypertension and hypoxemia has not been critically evaluated.
150 ; 95% CI, 2.33-3.28; p < 0.01) and of severe hypoxemia (hazard ratio, 1.29; 95% CI, 1.14-1.47; p < 0.
151 , since he developed progressive dyspnea and hypoxemia, he was admitted to our hospital.
152  Obstructive sleep apnea causes intermittent hypoxemia, hemodynamic fluctuations, and sleep fragmenta
153 ressure level of 40 mm Hg during 30 minutes, hypoxemia-hemorrhagic shock group in which PaO2 was decr
154 opped in a synergistic manner (69% +/- 3% in hypoxemia-hemorrhagic shock group vs 94 +/- 2 in hemorrh
155 igations in animals suggest that concomitant hypoxemia hinders resuscitation attempts, and that epine
156            Carotid body chemoreceptors sense hypoxemia, hypercapnia, and acidosis and play an importa
157 in total lung capacity, resulting in chronic hypoxemia, hypercapnia, and increased erythropoietin syn
158 e high risk for death associated with severe hypoxemia, hypercapnia, or both not responding to maximi
159 e high risk for death associated with severe hypoxemia, hypercapnia, or both not responding to maximi
160 ologic (Glasgow Coma Scale) and respiratory (hypoxemia, hypercapnia, or nursing requirements for comp
161 physiologically detrimental conditions (e.g. hypoxemia, hypercarbia, acidosis, hypothermia, hypervole
162                 Every blood gas derangement (hypoxemia, hyperoxemia, hypocapnia, hypercapnia, and aci
163 ery are reviewed, relative to the threats of hypoxemia, hyperoxia and mechanical lung injury.
164  in adults, the initial severity of arterial hypoxemia in children correlates well with mortality.
165 fetuses enhanced the vasodilator response to hypoxemia in circulations in which blood flow is known t
166                            The management of hypoxemia in critically ill patients is challenging.
167 vel related strategies for the management of hypoxemia in critically ill patients.
168 ation-perfusion mismatch is a major cause of hypoxemia in cystic fibrosis.
169 on (PAH) is commonly associated with chronic hypoxemia in disorders such as chronic obstructive pulmo
170 ve signals all noninvasively-measured during hypoxemia in healthy volunteers include four signals mea
171 ere selected that explored the physiology of hypoxemia in healthy volunteers or critically ill patien
172 corporeal membrane oxygenation) to alleviate hypoxemia in patients unable to maintain reasonable oxyg
173 oes not appear to lead to increased rates of hypoxemia in patients undergoing ambulatory upper endosc
174 etermine the incidence and severity of ictal hypoxemia in patients with localization-related epilepsy
175 med on these 25 subjects to examine cerebral hypoxemia in specific regions (periventricular white mat
176                                    Nocturnal hypoxemia in subjects at high risk for OSA was associate
177 ol metabolism in erythrocytes, and implicate hypoxemia in the pathobiology of erythrocyte-based vascu
178 ric results, whereas there was more profound hypoxemia in the PH group.
179 esponses to stress and diminished arousal to hypoxemia, in part because of failures in genetically de
180 entrations; each 10% increase in duration of hypoxemia increased BNP by 9.6% (95% confidence interval
181 ociation of HD with severe SDB and nocturnal hypoxemia independent of age, BMI, and the higher preval
182 cally derived apnea-hypopnea index (AHI) and hypoxemia index (percent of sleep time with oxyhemoglobi
183 using the apnea-hypopnea index (AHI) and the hypoxemia index (percent sleep time below 90% oxyhemoglo
184 number of apneas/hypopneas per hour) and the hypoxemia index (percentage of time below 90% O2 saturat
185 s significantly associated with both AHI and hypoxemia index after adjustment for age, sex, ethnicity
186 ckness was significantly associated with the hypoxemia index but not with AHI.
187                      A higher AHI and higher hypoxemia index were also associated with larger LV dias
188 For categories of increasing severity of the hypoxemia index, the corresponding relative hazards were
189                    The severity of nocturnal hypoxemia influences the magnitude of renal, but not the
190 inority of patients with ARDS and refractory hypoxemia, institution of these therapies may be conside
191                                   Refractory hypoxemia is a common finding in these patients and can
192                                   Permissive hypoxemia is a concept that is untested clinically and r
193                                              Hypoxemia is a feared complication of acute liver failur
194                                              Hypoxemia is a risk factor for long-term neuropsychologi
195  to many pathophysiological causes; avoiding hypoxemia is an important objective during neonatal anes
196                                     Arterial hypoxemia is associated with cerebral and retinal venous
197                                              Hypoxemia is common during endotracheal intubation of cr
198                                              Hypoxemia is common in diabetes, and reflex responses to
199                                       Tissue hypoxemia is common in several pathological diseases, in
200                                              Hypoxemia is due to many pathophysiological causes; avoi
201 are consistent with an injury model in which hypoxemia is exacerbated by endotoxin-mediated failure o
202                                              Hypoxemia is mainly due to intrapulmonary shunt, whereas
203                        The aim of permissive hypoxemia is to minimize the possible harms caused by re
204 current arousals from sleep and intermittent hypoxemia) is common among older adults.
205 clude species that tolerate acute or chronic hypoxemia like deep-diving mammals and high-altitude inh
206 d in reduced carotid arterial O2 saturation (hypoxemia), lung pathology, pulmonary edema, reduced lun
207           Lipoplexes induced no weight loss, hypoxemia, lung dysfunction, pulmonary edema, or pulmona
208 fits of attempting to fully reverse arterial hypoxemia may be outweighed by the harms associated with
209                           Since intermittent hypoxemia may underlie cardiovascular sequelae of sleep
210 r other interventions targeted at mitigating hypoxemia, may be inadequately appreciated.
211   Acute interventions specifically targeting hypoxemia, metabolic acidosis, hyperglycemia, and cardio
212 lusive categories of ARDS based on degree of hypoxemia: mild (200 mm Hg < PaO2/FIO2 </= 300 mm Hg)
213                                   The severe hypoxemia, moderate volume loss, and perfusion patterns
214 sk intolerance (n = 11, 30%), and refractory hypoxemia (n = 1, 2.7%).
215 ratory distress syndrome use some measure of hypoxemia, neither the Berlin definition nor recently pr
216                                        Ictal hypoxemia occurs often in patients with localization-rel
217 rotective factor of the occurrence of severe hypoxemia (odds ratio, 0.146; 95% CI, 0.01-0.90; p = 0.0
218 -venous extracorporeal membrane oxygenation, hypoxemia (odds ratio, 1.68; 95% CI, 1.09-2.57) and mode
219                               In conclusion, hypoxemia of HPS is frequently progressive.
220 gy to withstand episodes of subsequent acute hypoxemia of the type that may occur during labor and de
221  improve survival among patients with severe hypoxemia on conventional mechanical ventilation.
222  fetuses were exposed to 2 episodes of acute hypoxemia, on separate days, during infusion with either
223  preterm infants may experience intermittent hypoxemia or bradycardia for many weeks after birth.
224 n to intestinal venules compared with either hypoxemia or hemorrhagic shock alone.
225  transient worsening of mismatch by episodic hypoxemia or hypotension also reproducibly triggers PIDs
226 n of the uterine vasculature during maternal hypoxemia or hypotension makes this goal a significant c
227  depression or airway obstruction leading to hypoxemia or hypoventilation.
228 anagement of isolated fast breathing without hypoxemia or other clinical signs of illness in term you
229  exposing children to recurrent intermittent hypoxemia or oxidative stress, may amplify the adverse e
230 tatus (mean nocturnal SaO2, >/=90% [moderate hypoxemia] or <90% [severe hypoxemia]) and 13 obese cont
231                     The presence of moderate hypoxemia (oxygen saturation </=96%; LR, 2.8 [95% CI, 2.
232 fference in coronary flow was accentuated by hypoxemia (P < 0.001).
233 , however, depending on baseline severity of hypoxemia (P = 0.0003), with harm increasing with PaO2/F
234  hypoxemia compared with those with moderate hypoxemia (P = 0.001) and obese control subjects after 3
235 n patients with COPD who have severe resting hypoxemia (Pao(2) </=55 mm Hg or Spo(2) </=88%) (Grade:
236                    The relationships between hypoxemia (PaO2 < 60mm Hg), normoxia (PaO2 60-100mm Hg),
237 en therapy in patients with COPD and resting hypoxemia (Pao2 < or =55 mm Hg).
238 ated patients admitted to the ICU with acute hypoxemia (PaO2/FIO2 </= 300) and bilateral opacities.
239 44 [54%] vs 135 [72%]; p=0.006), more severe hypoxemia (PaO2/FIO2: 165+/-73 mm Hg vs 199+/-79 mm Hg;
240                                       Severe hypoxemia percentages in the blinded and open arms were
241 bariatric surgery, the severity of nocturnal hypoxemia predicted Angptl4 levels in subcutaneous adipo
242 CI, 1.13-4.56), but not obstructive apnea or hypoxemia, predicted incident atrial fibrillation.
243                                              Hypoxemia, pulmonary edema, and levels of BALF alveolar
244 and critical care medicine, including apnea, hypoxemia, pulmonary hypertension, asthma, cystic fibros
245                                  Episodes of hypoxemia (pulse oximeter oxygen saturation <80%) or bra
246 vels correlated with the degree of nocturnal hypoxemia (r=0.68, P=0.001).
247                       CPAP corrected OSA and hypoxemia (RDI: 42 +/- 4 vs. 4 +/- 1 h(-1), P < 0.001; d
248 emental approach to the management of severe hypoxemia requires implementation of the strategies revi
249  unit patients) were characterized by severe hypoxemia (requiring high levels of inspired oxygen and
250                                              Hypoxemia resolved after the institution of chemotherapy
251                                Tachypnea and hypoxemia resolved faster in older children (P = 0.0001)
252 re indicated in cases of fluid retention and hypoxemia, respectively.
253 opulmonary resuscitation results in profound hypoxemia, respiratory acidosis, and significantly worse
254 eatening situations associated with profound hypoxemia, respiratory acidosis, or hemodynamic compromi
255 markers of obstructive sleep apnea severity (hypoxemia, respiratory disturbances, and sleep fragmenta
256 ertrophy and thickening were associated with hypoxemia, respiratory disturbances, and sleep fragmenta
257 on to lower respiratory tract disease (LRD), hypoxemia, respiratory failure, and overall and influenz
258 After WLS, there was rapid onset of profound hypoxemia resulting in acute pulmonary hypertension and
259 s of overwhelming pulmonary inflammation and hypoxemia, resulting in high morbidity and mortality.
260                      Intriguingly, postnatal hypoxemia, ROS scavenging, or inhibition of DDR all prol
261 bance index [RDI] > 15 h(-1)) with nocturnal hypoxemia (SaO2 < 90% for >12% of the night) were studie
262  not demonstrate any effect on postoperative hypoxemia, Sao2 level, or postoperative pulmonary compli
263  The primary end point was the occurrence of hypoxemia; secondary end points were the occurrences of
264 e presence of terminal illness, tachypnea or hypoxemia, septic shock, platelet count <150,000 cells/m
265 ective ERCP/EUS by reducing the frequency of hypoxemia, severe hypoxemia, and apnea.
266  OSA) were higher in OSA and correlated with hypoxemia severity.
267 adherence, major complications, and rates of hypoxemia (SpO2 <90%).
268 25 h(-1)), stratified according to nocturnal hypoxemia status (mean nocturnal SaO2, >/=90% [moderate
269  management) were similar in mild and severe hypoxemia subsets as defined by PaO(2)/Fio(2) ratios.
270 ients with critical illness characterized by hypoxemia such as acute respiratory distress syndrome.
271 of severe respiratory failure and refractory hypoxemia such as that seen in patients with severe acut
272 blood flow is known to increase during acute hypoxemia, such as the umbilical vascular bed.
273                       However, the burden of hypoxemia (the time spent with oxygen saturation <90%) s
274          In patients with moderate-to-severe hypoxemia, the expired tidal volume above 9.5 mL/kg pred
275                      After 5 days of chronic hypoxemia, the umbilical cord was completely occluded fo
276             Secondly, we describe permissive hypoxemia: the acceptance of levels of arterial oxygenat
277 epatopulmonary syndrome leads to progressive hypoxemia through diffuse vasodilatation of the pulmonar
278 ral vasoconstriction during subsequent acute hypoxemia through elevated nitric oxide (NO) activity.
279                             Some measures of hypoxemia to guide 'need' for transfusion have potential
280 o evaluate adherence to process measures and hypoxemia trends over time.
281                Finally, we chemically induce hypoxemia via hemolytic anemia resulting in HIF stabiliz
282 nsing is essential to avoid life-threatening hypoxemia via hypoxic pulmonary vasoconstriction (HPV) w
283                                Sleep-related hypoxemia was also associated with glucose intolerance i
284 rease in Kupffer cell phagocytosis following hypoxemia was also prevented by Wortmannin or YC-1 treat
285                                         When hypoxemia was associated to hemorrhagic shock, it decrea
286                                              Hypoxemia was associated with an increased mortality in
287                                    Worsening hypoxemia was associated with initiation of rescue thera
288                                This level of hypoxemia was insufficient to affect the occurrence of a
289                                     In vivo, hypoxemia was more severe in Cx40-/- mice than in wild-t
290                                  Severity of hypoxemia was not associated with the blood pressure or
291 ected myocardial infarction who did not have hypoxemia was not found to reduce 1-year all-cause morta
292 erichia coli endotoxin infusion until severe hypoxemia was obtained.
293 ith hyperleukocytosis are at risk for severe hypoxemia, which may be real or spurious.
294 ent in patients treated with efaproxiral was hypoxemia, which was reversible and effectively managed
295 ivation and accumulation in the lung lead to hypoxemia, widespread tissue damage, and respiratory fai
296 xycycline caused progressive lung injury and hypoxemia with a high mortality rate.
297 ired vasodilation and oxygen delivery during hypoxemia with advancing age.
298 scopy following hypoventilation may decrease hypoxemia without compromising patient tolerance.
299   Thus, an effective and rapid treatment for hypoxemia would be revolutionary.
300 n to function as an early warning system for hypoxemia, would decrease hypoxemia during endoscopy.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top